ArticleMolecular cancer therapeutics2022

Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma.

Sehrish Javaid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.